IPI Legacy Liquidation Co
IMPLDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001445499
IPI Legacy Liquidation Co was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Apr 9, 2024; 32 institutions reported holding it in 13F filings for Q3 2023, worth $7.35M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 32
- Q3 2023, 0 vs. previous quarter
- 13F value
- $7.35M
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding IMPL, Q3 2023
No superinvestor reported holding IMPL at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by IPI Legacy Liquidation Co insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 (view filing)6:00 PM ET | Dec 15-19 | 4 days | Vivo Capital Fund VIII, L.P. and 2 others10% Owner | SSale | −575.0K | $0.1289 | −$74.1K | −67.2%280.3K after | 6 lots |
| Nov 22, 2021 (view filing) | Nov 19 | 3 days | Nelson Timothy SDirector | PPurchase | +10.0K | $10.76 | +$107.6K | New position10.0K after | |
| Aug 19, 2021 (view filing) | Aug 18 | 1 day | Adams AdrianCOB, CEO and President | PPurchase | +20.0K | $13.99 | +$279.9K | New position20.0K after | 3 lots |
Top 10 13F holders, Q3 2023
The largest institutional positions in IPI Legacy Liquidation Co at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $1.78M | 0.06% | 00.0% | Unchanged |
| NVP Associates, LLC | 3,077,198 | $1.32M | 1.18% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 2,884,791 | $1.24M | 0.36% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,884,789 | $1.24M | 0.15% | 00.0% | Unchanged |
| venBio Partners LLC | 2,759,791 | $1.19M | 0.34% | 00.0% | Unchanged |
| Vanguard Group Inc | 505,231 | $217.2K | 0.00% | −2,645−0.5% | Reduced |
| Lasry Marc | 225,874 | $97.1K | 0.10% | −182,455−44.7% | Reduced |
| DCF Advisers, LLC | 178,500 | $76.8K | 0.05% | −125,105−41.2% | Reduced |
| Geode Capital Management, LLC | 172,218 | $74.1K | 0.00% | +17,258+11.1% | Added |
| Bank of New York Mellon Corp | 35,301 | $15.2K | 0.00% | 00.0% | Unchanged |